A 2026 Johns Hopkins study links lower thoracic spinal bone density to faster cognitive decline, suggesting shared aging factors rather than a direct cause.
In 2026, researchers from Johns Hopkins University published a study finding that lower bone mineral density in the thoracic spine was associated with faster global cognitive decline. The research was published in the journal Radiology. The study also found that lower spinal bone density was linked to greater age-related white-matter injury in the brain.
Researchers conducted a secondary analysis of data from the Multi-Ethnic Study of Atherosclerosis, or MESA. The initial analysis began with noncontrast chest CT scans from 2,086 participants. However, not all initial participants had the necessary data for a complete comparison. The final cohort included 715 people who had established thoracic vertebral volumetric bone mineral density, brain MRI, and cognitive testing.
The participants with complete data represented 715 of the 2,086 people whose baseline CT scans were assessed. The numbers were smaller for the longitudinal MRI analyses. Longitudinal white-matter hyperintensity data were available for 408 participants. Fractional-anisotropy data were available for 405 participants, while global cognitive composite data were available for 639 participants.
To evaluate skeletal health, the study used a deep-learning algorithm. This tool was developed in the laboratory of Johns Hopkins radiologist Shadpour Demehri, M.D. The algorithm calculated baseline vertebral volumetric bone mineral density directly from the chest CT scans. Researchers found that lower baseline spinal bone density was associated with a faster decline in global cognition.
Brain imaging analysis revealed additional structural changes associated with skeletal health. Lower bone density was associated with the accumulation of white-matter hyperintensities in the corpus callosum. The corpus callosum is a region involved in executive function, working memory, and attention. The study further linked lower vertebral bone density with a steeper decline in total white-matter fractional anisotropy.
This decline in fractional anisotropy occurred in the anterior limb of the internal capsule. This area is another region involved in executive function. Demehri described the findings as a signal that baseline bone density is associated with brain aging. He noted it relates to both functional and imaging measures of age-related brain degeneration.
Demehri also highlighted the novelty of this analytical approach. He stated that the study was the first longitudinal secondary analysis linking baseline vertebral bone mineral density to changes in white matter structure. It was also the first to link this baseline density to white matter hyperintensity progression and cognition.
This study illustrates a broader use of artificial intelligence in medical imaging. Medical professionals can now use AI to extract information about multiple organ systems from scans originally ordered for another clinical reason. Artificial intelligence could help connect coexisting age-related conditions that have traditionally been studied separately. This technology could also help identify shared biological pathways across different bodily systems.
Sara Momtazmanesh, M.D., commented on the practical utility of this approach for older adults. She noted that chest CT scans obtained for lung-cancer screening could potentially provide an opportunistic measurement of thoracic-spine bone density. Scans performed for coronary-calcium assessment and pulmonary-nodule follow-up might also serve this dual purpose.
The researchers suggested that identifying low vertebral bone density could help flag people for earlier assessment. This early identification might lead to the shared management of risk factors affecting skeletal and neurological health. The RSNA has highlighted opportunistic osteoporosis screening from existing medical images as a related area of research.
Historically, conditions like bone loss and cognitive decline have required completely separate testing protocols. If an older adult is already scheduled for a clinically indicated chest CT, they could ask if the scan contains information relevant to bone health. This could prompt a helpful clinical conversation about skeletal risk, physical activity, and sensible lifestyle routines.
While these imaging advancements are notable, readers must view the findings objectively. This was a secondary analysis of an existing observational dataset rather than a randomized intervention study. An association between lower spinal bone density and cognitive decline does not prove that low bone density causes neurological deterioration. Demehri stated clearly that the study was not about cause and effect.
The findings do not show that osteoporosis causes dementia. According to Demehri, the relationship may reflect shared aging and metabolic factors that affect both bone and brain health. These shared drivers include insulin resistance, dyslipidemia, and menopausal change. Because these systemic factors contribute to both skeletal and brain degeneration, the finding should be viewed as a possible risk marker.
The publicly reported study materials lack specific clinical test-performance measures. The research did not establish a numerical dementia risk, a validated prediction score, sensitivity, or specificity. The available reports do not provide a follow-up duration, confidence intervals, p-values, or a percentage increase in dementia risk. They also do not provide a validated threshold for low spinal bone density that clinicians can use to identify cognitive risk.
The researchers did report effect modification by diabetes status for white-matter-hyperintensity accumulation. They also noted suggestive effect modification by sex for fractional-anisotropy change. However, the available report does not provide detailed subgroup effect estimates. Treating a normal bone-density result as proof that cognitive decline cannot occur would be incorrect.
The findings should not be interpreted as showing that everyone with osteoporosis will develop dementia. Treating osteoporosis also will not necessarily prevent cognitive decline. It is not a direct bone-to-brain explanation.
Routine clinical implementation of opportunistic chest CT screening is not currently available. The study does not show that routine chest CT scanning should be performed solely to assess cognitive risk. It also does not establish a clinical protocol for AI-based bone-density screening. Opportunistic CT analysis remains an emerging approach rather than a universally validated cognitive-screening test.
Doctors cannot yet use these AI algorithms as standard diagnostic tools for memory care. The available reports do not show that acting on the CT-derived measurement improves memory, independence, fracture outcomes, or dementia outcomes. Further research is required to determine if opportunistic bone density measurements can reliably predict future neurological changes. Any future mainstream use will require rigorous validation to confirm clinical utility.
For adults over 60, this research reinforces the value of addressing physical and mental aging together. Bone health and brain health can reasonably be discussed together because both are highly relevant to maintaining mobility, independence, and participation in everyday activities. However, this study does not prove that improving bone density will preserve cognition. The biological connection between them still requires further research.
Adults should not wait for cognitive symptoms before discussing fracture risk, osteoporosis assessment, and falls prevention with a clinician. This is particularly relevant if they have known bone loss or other relevant risk factors. A sensible clinical conversation might cover skeletal risk, blood pressure, diabetes, and physical activity. This discussion can also include subjective memory concerns, especially since researchers raised shared metabolic pathways as a potential explanation.
The study itself did not test a specific prevention program. People should not interpret a low bone-density result as proof that dementia is inevitable. Staying physically active helps older adults maintain an independent lifestyle. This physical capability allows individuals to participate in meaningful daily routines and social activities.
Maintaining skeletal strength is a practical foundation for cognitive longevity because it supports ongoing physical engagement. Maintaining healthy metabolic factors like insulin sensitivity and blood lipids can support both brain resilience and physical mobility.
Once you understand how physical factors like bone density relate to brain aging, the next step involves organizing daily habits that keep your mind challenged. Overcoming the loss of structure, learning opportunities or purpose after retirement requires sensible planning, and FitBrainLab translates complex clinical research into clear guidance to help you confidently build a meaningful routine.
Follow FitBrainLab for research-led insights on memory, focus, brain aging, nutrition and mental fitness after 60. Stay connected for new articles, practical guidance and ideas for a sharper, more engaged life.
Build habits that support memory, focus and a curious, connected life.
Read the Blog
